Dr Allan Pamba, Director Public Engagement & Access Initiatives at GSK.

A healthier future for Africa

Our VP of east Africa and government affairs, Allan Pamba, explains how growing up and working in Kenya motivates his desire to improve the health of people in the continent

Growing up in Kenya, I was one of the lucky ones. I survived malaria to see my fifth birthday. But hundreds of thousands of children each year are not so fortunate.

This insidious disease still claims more than 600,000 lives each year – most of them children under five in sub-Saharan Africa.

These investments are intended to help address pressing health needs across the region, build capacity and create sustainable growth and jobs.

As well as improving access to healthcare through changing our business practices, it is exciting to see the difference scientific innovation can make. Our scientists are at the frontline of developing new HIV treatments; we have opened our laboratory doors to visiting scientists in an effort to find new interventions against neglected tropical diseases; and with our partners, we’re in the final stages of developing a vaccine against malaria – a world first.

When at medical school in Kenya, I never imagined I would work in the healthcare industry. But I realised that rather than fighting companies, I could do more from the inside – by helping to change ways of working and forging innovative partnerships with other organisations.

Our initiatives show that when business does what it does best – in GSK’s case developing innovative medicines and delivering them where needed – and at the same time working creatively with others, we have the potential to make a real difference.


2015 Pulse Impact Report

Download the report

save the children infographic

Save The Children Partnership

Download the infographic